Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

• Main Authors: Juan M. Decara (Author), Francisco Javier Pavón (Author), Juan Suárez (Author), Miguel Romero-Cuevas (Author), Elena Baixeras (Author), Mariam Vázquez (Author), Patricia Rivera (Author), Ana L. Gavito (Author), Bruno Almeida (Author), Jesús Joglar (Author), Rafael de la Torre (Author), Fernando Rodríguez de Fonseca (Author), Antonia Serrano (Author)
• Format: Book
• Published: The Company of Biologists, 2015-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Fatty liver disease is one of the main hepatic complications associated with obesity. To date, there are no effective treatments for this pathology apart from the use of classical fibrates. In this study, we have characterized the in vivo effects of a novel conjugation of oleic acid with an amphetam...